MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Marrone Bio Innovations Company Profile (NASDAQ:MBII)

Consensus Ratings for Marrone Bio Innovations (NASDAQ:MBII) (?)
Ratings Breakdown: 1 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $15.00 (1,430.61% upside)

Analysts' Ratings History for Marrone Bio Innovations (NASDAQ:MBII)
Show:
DateFirmActionRatingPrice TargetActions
12/31/2015Roth CapitalReiterated RatingBuy -> Not Rated$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2015Jefferies GroupDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014Stifel NicolausLower Price TargetBuy$16.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Robert W. BairdDowngradeOutperform -> Neutral$15.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Piper JaffrayDowngradeOverweight -> Neutral$19.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2014Robert W. BairdInitiated CoverageOutperform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2014Jefferies GroupLower Price TargetBuy$23.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/11/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha